Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 94.31% | 86.69% | 58.88% | 36.53% | 54.82% |
| Total Depreciation and Amortization | 50.97% | 108.68% | 252.15% | 205.85% | 150.69% |
| Total Amortization of Deferred Charges | -61.52% | 216.53% | 217.62% | 234.42% | 200.00% |
| Total Other Non-Cash Items | -3.15% | -22.29% | 5.11% | 16.44% | 26.92% |
| Change in Net Operating Assets | 78.92% | 64.48% | -2,616.85% | -223.84% | -240.73% |
| Cash from Operations | 144.65% | 134.74% | 30.69% | 28.00% | 44.40% |
| Capital Expenditure | -255.99% | -102.77% | -13.62% | 29.97% | -1.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -140.16% | -117.21% | 205.61% | 171.23% | 553.90% |
| Cash from Investing | -59.80% | -37.66% | -7.45% | -36.28% | -27.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 65.74% | 64.06% | 62.58% | 71.90% | 74.30% |
| Issuance of Common Stock | -31.49% | -45.57% | -- | 2.70% | -1.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32,480.00% | -2,081.40% | -- | 97.38% | 97.38% |
| Cash from Financing | -35.21% | -37.48% | 264.01% | -33.26% | -29.77% |
| Foreign Exchange rate Adjustments | -25.00% | 40.00% | 25.00% | 80.00% | -33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 696.87% | 187.70% | 113.31% | -533.88% | 64.79% |